Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials.
Eiichi ArakiYasuo TerauchiHirotaka WatadaSrikanth DeenadayalanErik ChristiansenHiroshi HorioTakashi KadowakiPublished in: Diabetes, obesity & metabolism (2021)
Oral semaglutide appears efficacious and well tolerated in Japanese patients across the type 2 diabetes spectrum.